Technical supplement – COVID-19 Australia: Epidemiology reporting - Last updated 29 March 2023
DOI:
https://doi.org/10.33321/cdi.2021.45.2Keywords:
SARS-CoV-2, novel coronavirus, 2019-nCoV, coronavirus disease 2019, COVID-19, acute respiratory disease, epidemiology, AustraliaAbstract
This supplement to the series of regular Australian coronavirus disease 2019 (COVID-19) epidemiological reports describes the technical background to the surveillance data reported through Communicable Diseases Network Australia (CDNA) as part of the nationally-coordinated response to COVID-19.
Downloads
References
World Health Organization (WHO). Speeches detail: WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020. [Internet.] Geneva: WHO; 11 March 2020. Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020.
WHO. Transmission of SARS-CoV-2: implications for infection prevention precautions. Scientific brief. [Internet.] Geneva: WHO; 9 July 2020. [Accessed on 14 October 2020.] Available from: https://www.who.int/news-room/commentaries/detail/transmission-of-sars-cov-2-implications-for-infection-prevention-precautions.
McAloon C, Collins Á, Hunt K, Barber A, Byrne AW, Butler F et al. Incubation period of COVID-19: a rapid systematic review and meta-analysis of observational research. BMJ Open. 2020;10(8). doi: https://doi.org/10.1136/bmjopen-2020-039652.
Australian Government Department of Health and Aged Care. Australian National Disease Surveillance Plan for COVID-19. [Internet.] Canberra: Australian Government Department of Health and Aged Care; 30 May 2020. Available from: https://www.health.gov.au/resources/publications/australian-national-disease-surveillance-plan-for-covid-19.
Yuan Z, Xiao Y, Dai Z, Huang J, Zhang Z, Chen Y. Modelling the effects of Wuhan’s lockdown during COVID-19, China. Bull World Health Organ. 2020;98(7):484–94.
Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020;109. doi: https://doi.org/10.1016/j.jaut.2020.102433.
Hu Y, Sun J, Dai Z, Deng H, Li X, Huang Q et al. Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis. J Clin Virol. 2020; 127. doi: https://doi.org/10.1016/j.jcv.2020.104371.
WHO. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). Geneva: WHO; 2020. [Accessed on 14 October 2020.] Available from: https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf.
Australian Government Federal Register of Legislation. National Health Security Act 2007. No. 174, 2007. Compilation No. 15. [Legislation.] Canberra: Australian Government, Federal Register of Legislation; 19 July 2016. Available from: https://www.legislation.gov.au/Details/C2016C00847.
Australian Government Department of Health and Aged Care. Coronavirus Disease 2019 (COVID-19): CDNA national guidelines for public health units. Canberra: Australian Government Department of Health and Aged Care. Available from: https://www.health.gov.au/resources/publications/coronavirus-covid-19-cdna-national-guidelines-for-public-health-units.
Dalton C, Durrheim D, Fejsa J, Francis L, Carlson S, d’Espaignet ET et al. Flutracking: a weekly Australian community online survey of influenza-like illness in 2006, 2007 and 2008. Commun Dis Intell Q Rep. 2009;33(3):316–22.
Monash Health. FluCAN (Influenza surveillance): FluCAN (The Influenza Complications Alert Network) [Internet.] Melbourne: Monash Health; 2020. Available from: https://monashhealth.org/services/monash-infectious-diseases/research/influenza-research/flucan-influenza-surveillance-2/.
Australian and New Zealand Intensive Care Society (ANZICS). SPRINT-SARI: Short period incidence study of severe acute respiratory infection. [Internet.] Camberwell: ANZICS; 2020. Available from: https://www.anzics.com.au/current-active-endorsed-research/sprint-sari/.
Global Initiative on Sharing All Influenza Data (GISAID). [Website.] Berlin: Federal Republic of Germany, Freunde von GISAID e.V.; 2020. Available from: https://www.gisaid.org/.
Rambaut A, Homles EC, O’Toole Á, Hill V, McCrone JT, Ruis C et al. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. Nat Microbiol. 2020;5:1403–7. doi: https://doi.org/10.1038/s41564-020-0770-5.
WHO. Tracking SARS-CoV-2 variants. [Internet.] Geneva: WHO; 1 June 2021. [Accessed on 10 June 2021.] Available from: https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/.
Network for Genomic Surveillance in South Africa (NGS-SA). Recording: Briefing on COVID-19 and vaccination programme developments 25 November 2021. [Video recording.] Durban: NGS-SA; 25 November 2021. [Accessed on 10 December 2021.] Available from: https://sacoronavirus.co.za/2021/11/25/recording-briefing-on-covid-19-and-vaccination-programme-developments-25-november-2021/.
WHO. Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern. [Internet.] Geneva: WHO; 26 November 2021. [Accessed on 10 Decmber 2021.] Available from: https://www.who.int/news-room/statements/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern.
WHO. WHO Coronavirus Disease (COVID-19) dashboard. [Internet.] Geneva: WHO; 2021. Available from: https://covid19.who.int/.
Australian Bureau of Statistics. Articles. Measuring excess mortality in Australia during the COVID-19 pandemic: methodology. [Internet.] Canberra: Australian Bureau of Statistics; 25 November 2020. [Accessed on 25 November 2020.] Available from: https://www.abs.gov.au/articles/measuring-excess-mortality-australia-during-covid-19-pandemic#methodology.
Centers for Disease Control and Prevention (CDC). COVID-19: SARS-CoV-2 Variant Classifications and Definitions. [Webpage.] Atlanta: Federal Government of the United States, Deaprtment of Health and Human Services, CDC; 26 April 2022. [Accessed on 7 February 2023.] Available from: https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-classifications.html.
Rambaut A, Loman N, Pybus O, Barclay W, Barrett J, Carabelli A et al. Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations. [Internet.] Virological. December 2020. Available from: https://virological.org/t/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563.
Tegally H, Wilkinson E, Giovanetti M, Iranzadeh A, Fonseca V, Giandhari J et al. Detection of a SARS-CoV-2 variant of concern inSouth Africa. Nature. 2021;592(7854):438-43. doi: https://doi.org/10.1038/s41586-021-03402-9.
Nelson G, Buzko O, Spilman P, Niazi K, Rabizadeh S, Soon-Shiong P. Molecular dynamic simulation reveals E484K mutation enhances spike RBD-ACE2 affinity and the combination of E484K, K417N and N501Y mutations (501Y.V2 variant) induces conformational change greater than N501Y mutant alone, potentially resulting in an escape mutant. bioRxiv. 2021. doi: https://doi.org/10.1101/2021.01.13.426558.
Faria NR, Claro IM, Candido D, Moyses Franco L, Andrade PS, Coletti TM et al. Genomic characterisation of an emergent SARS-CoV-2 lineage in Manaus: preliminary findings. [Internet.] Virological. 13 January 2021. Available from: https://virological.org/t/genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-manaus-preliminary-findings/586.
Naveca F, Nascimento V, Souza V, Corado A, Nascimento F, Silva G et al. Phylogenetic relationship of SARS-CoV-2 sequences from Amazonas with emerging Brazilian variants harboring mutations E484K and N501Y in the Spike protein. [Internet.] Virological. 12 January 2021. Available from: https://virological.org/t/phylogenetic-relationship-of-sars-cov-2-sequences-from-amazonas-with-emerging-brazilian-variants-harboring-mutations-e484k-and-n501y-in-the-spike-protein/585.
Phylogenetic Assignment of Named Global Outbreak Lineages (PANGOLIN). Proposed new B.1 sublineage circulating in India #38. [Webpage.] San Francisco: GitHub; 30 March 2021. [Accessed on 18 October 2021.] Available from: https://github.com/cov-lineages/pango-designation/issues/38.
Public Health England (PHE). SARS-CoV-2 variants of concern and variants under investigation in England. Technical briefing 9. London: United Kingdom Government Department of Health and Social Care, PHE; 22 April 2021. [Accessed on 18 October 2021.] Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/979818/Variants_of_Concern_VOC_Technical_Briefing_9_England.pdf.
PHE. SARS-CoV-2 variants of concern and variants under investigation in England. Technical briefing 10. London: United Kingdom Government Department of Health and Social Care, PHE; 7 May 2021. [Accessed on 18 October 2021.] Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/984274/Variants_of_Concern_VOC_Technical_Briefing_10_England.pdf.
WHO. Weekly epidemiological update on COVID-19 - 11 May 2021. [Internet.] Geneva: WHO; 11 May 2021. [Accessed on 18 October 2021.] Available from: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---11-may-2021.
WHO. Weekly epidemiological update on COVID-19 - 1 June 2021. [Internet.] Geneva: WHO; 1 June 2021. [Accessed on 18 October 2021.] Available from: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---1-june-2021.
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2021 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
